Views: 1,540 | Downloads:
213
| Responses: 0
| XML | Respond to this article | Alert & updates | Request permissions | Email to a friend |
Original ArticleOpen Access
Choice of Colloidal Solutions in Dengue Hemorrhagic Fever Patients
Kalayanarooj S 
Background: DHF is characterized by plasma leakage and abnormal hemostasis. About 20% of DHF patients
do require colloidal solution in addition to conventional crystalloid solution for the treatment. There is only
one colloidal solution, 10% Dextran-40 in NSS that proved to be effective for this group of DHF patients.
Objective: To compare 10% dextran-40 in NSS with 10% Haes-steril in NSS in the management of DHF cases
with severe plasma leakage for their effectiveness and impact on renal function, hemostasis, disease severity,
and complications.
Material and Method: DHF patients admitted to Dengue Unit, QSNICH, who do not respond to conventional
crystalloid solution, are randomly assigned to receive either dextran or haes-steril. Clinical and laboratory
comparison are recorded and analyzed using SPSS for Window version 14.0.
Results: There are 104 DHF patients enrolled in the study; 57 are assigned in dextran and 47 in haes-steril
group. The mean ages are 8.6 + 3.9 years. About half of the patients in both groups require one dose of
colloidal solution and 25% require 2 and 3 doses (p = 0.138). The average amount of IV fluid infused in
dextran and haes-steril group are 119.4 and 129.3 ml (p = 0.227). The average drop in Hct after the bolus dose
of both colloid are 7.9 and 8.5% (p = 0.381). About 80% of the patients in each group have shock (p = 0.843).
The mean elevation of AST are 598 and 822 U (p = 0.548) while ALT elevation are 182 and 306 U (p = 0.265)
in dextran and haes-steril group, respectively. BUN and creatinine are within normal limits and are decreased
after the use of colloidal solutions. The amount of urine on day 1, 2 and 3 after the use of both colloidal
solutions are not different. Coagulogram studies (PT, PTT and TT) in both groups are not different. Patients
with significant bleeding and who require blood transfusions are 15.8 and 19.2% in dextran and haes-steril
group (p = 0.423).The incidence of fluid overload in dextran and haes-steril group are 35.1 and 40.4% (p =
0.360). Other complications are not different between dextran and haes-steril group as follows: hypocalcaemia,
hyponatremia, hypokalemia and acidosis. The overall severity and complications in both groups of patients
are much higher than in DHF patients who respond to conventional crystalloid solution. No allergic reaction
was found after the use of both colloidal solutions.
Conclusion: 10% Haes-steril is as effective as 10% dextran-40 in the treatment of DHF patients who have
severe plasma leakage. There are no differences in DHF disease severity and complications in both groups but
the disease severity and complications, especially fluid overload are observed to be more comparative with
admitted DHF patients. Both colloidal solutions are safe in DHF patients with no allergic reaction observed
and no interference in renal functions and hemostasis.
Keywords: DHF, Severe plasma leakage, Colloidal solution, Fluid overload
do require colloidal solution in addition to conventional crystalloid solution for the treatment. There is only
one colloidal solution, 10% Dextran-40 in NSS that proved to be effective for this group of DHF patients.
Objective: To compare 10% dextran-40 in NSS with 10% Haes-steril in NSS in the management of DHF cases
with severe plasma leakage for their effectiveness and impact on renal function, hemostasis, disease severity,
and complications.
Material and Method: DHF patients admitted to Dengue Unit, QSNICH, who do not respond to conventional
crystalloid solution, are randomly assigned to receive either dextran or haes-steril. Clinical and laboratory
comparison are recorded and analyzed using SPSS for Window version 14.0.
Results: There are 104 DHF patients enrolled in the study; 57 are assigned in dextran and 47 in haes-steril
group. The mean ages are 8.6 + 3.9 years. About half of the patients in both groups require one dose of
colloidal solution and 25% require 2 and 3 doses (p = 0.138). The average amount of IV fluid infused in
dextran and haes-steril group are 119.4 and 129.3 ml (p = 0.227). The average drop in Hct after the bolus dose
of both colloid are 7.9 and 8.5% (p = 0.381). About 80% of the patients in each group have shock (p = 0.843).
The mean elevation of AST are 598 and 822 U (p = 0.548) while ALT elevation are 182 and 306 U (p = 0.265)
in dextran and haes-steril group, respectively. BUN and creatinine are within normal limits and are decreased
after the use of colloidal solutions. The amount of urine on day 1, 2 and 3 after the use of both colloidal
solutions are not different. Coagulogram studies (PT, PTT and TT) in both groups are not different. Patients
with significant bleeding and who require blood transfusions are 15.8 and 19.2% in dextran and haes-steril
group (p = 0.423).The incidence of fluid overload in dextran and haes-steril group are 35.1 and 40.4% (p =
0.360). Other complications are not different between dextran and haes-steril group as follows: hypocalcaemia,
hyponatremia, hypokalemia and acidosis. The overall severity and complications in both groups of patients
are much higher than in DHF patients who respond to conventional crystalloid solution. No allergic reaction
was found after the use of both colloidal solutions.
Conclusion: 10% Haes-steril is as effective as 10% dextran-40 in the treatment of DHF patients who have
severe plasma leakage. There are no differences in DHF disease severity and complications in both groups but
the disease severity and complications, especially fluid overload are observed to be more comparative with
admitted DHF patients. Both colloidal solutions are safe in DHF patients with no allergic reaction observed
and no interference in renal functions and hemostasis.
Keywords: DHF, Severe plasma leakage, Colloidal solution, Fluid overload
Download:
PDF